The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Seven life scientists are among the 15 honorees for this year's National Academy of Sciences award ceremony set for today at the NAS's 135th annual meeting in Washington, D.C. The meeting also includes the induction of academy members elected last year (E.R. Silverman, The Scientist, 11[9]:1, April 28, 1997). The academy is presenting its highest honor, the Public Welfare Medal, to David A. Hamburg, president emeritus of the Carnegie Corp. of New York. Hamburg, 72, is being recognized "for his

Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst

Critics Charge Author: FRANKLIN HOKE, pp.1 Date: July 11,1994 Disputing what they see as unproductive preoccupation with HIV-specific studies, they step up campaign for a `wider window' of research Progress in AIDS research has faltered in the United States since the mid-1980s, according to some scientists, owing to a premature narrowing of the research focus by the scientific and administrative leadership of the National Inst

Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading

AUTHOR: REBECCA KRUMM, pp.17 Date: May 16,1994 SUPPLIERS OF RADIOIMMUNOASSAY KITS, REAGENTS, AND SUPPLIES The following companies offer radioimmunoassay supplies and equipment. Please contact the companies directly for more information concerning specific products. Advanced Chemtech 5609 Fern Valley Rd. Louisville, Ky. 40228 (502) 969-0000 Fax: (502) 968-1000 AMAC Inc. 160B Larrabee Rd. Westbrook, Maine 04092 (207) 854-0426 Fax

AUTHOR: REBECCA KRUMM, pp.17 Date: May 16,1994 SUPPLIERS OF RADIOIMMUNOASSAY KITS, REAGENTS, AND SUPPLIES The following companies offer radioimmunoassay supplies and equipment. Please contact the companies directly for more information concerning specific products. Advanced Chemtech 5609 Fern Valley Rd. Louisville, Ky. 40228 (502) 969-0000 Fax: (502) 968-1000 AMAC Inc. 160B Larrabee Rd. Westbrook, Maine 04092 (207) 854-0426 Fax

On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,